Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

Clinical trial NCT03969446 · SUSPENDED

Trial details

NCT number: NCT03969446
Sponsor: City of Hope Medical Center
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory Myelodysplastic Syndrome

Start date: 2020-05-04
Primary completion: 2027-07-04
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.